Jacqualyn A. Fouse
Overview
Jacqualyn A. Fouse received an average of $10M in total compensation, including $724K in salary, at Agios Pharmaceuticals from 2019 to 2021. Jacqualyn Fouse also received an average of $6M at Celgene from 2010 to 2015 and an average of $3M at Bunge from 2007 to 2010.
- 2021
- 2020
- 2019
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
Agios PharmaceuticalsChief Executive Officer
Agios PharmaceuticalsChief Executive Officer
Agios PharmaceuticalsChief Executive Officer
CelgenePresident Hematology and Oncology
CelgenePresident Hematology and Oncology
CelgenePresident Hematology and Oncology
CelgenePresident Hematology and Oncology
CelgeneExecutive Vice President and Chief Financial Officer
BungeFormer Chief Financial Officer
CelgeneExecutive Vice President and Chief Financial Officer
Source: SEC filings on April 28, 2022, April 8, 2021, April 16, 2020, April 28, 2016, April 30, 2015, April 28, 2014, April 18, 2011, April 30, 2013, and April 16, 2010.
Related executives
We found 39 more executives who work or worked at Agios Pharmaceuticals, Celgene, andBunge.
Gregory Heckman
Bunge
Chief Executive Officer
Brian Zachman
Bunge
President, Global Risk Management
Christos Dimopoulos
Bunge
President, Global Supply Chains
John Neppl
Bunge
Chief Financial Officer
Raul Padilla
Bunge
President, Global Operations
Jonathan Biller
Agios Pharmaceuticals
Chief Financial Officer
Bruce Car
Agios Pharmaceuticals
Chief Scientific Officer
Christopher Bowden
Agios Pharmaceuticals